Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde regimen in metastatic pancreatic adenocarcinoma
Phase III NAPOLI 3 trial is the largest and has the longest…
Terranet invites you to a digital investor meeting on June 3, 2025
In connection with the subscription period for Terranet AB’s rights issue of…
Terranet publishes information memorandum in connection with rights issue of units
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY…
Ipsen – April 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
Ipsen announces issuance of 500 million inaugural Rated Public Bond
Transaction follows Investment Grade ratings assignment from both S&P and Moody’s PARIS,…
Ipsen S.A. publishes its 2024 consolidated financial statements
Accessibility: Skip TopNav February 21, 2025 09:42 ET | Source: Ipsen Pharma…
Terranet AB – Year-end report 2024
Significant events during the fourth quarter Agreement with an actor in the…
The last day of trading with the warrants of series TO8 in Terranet AB is today, November 26th, 2024
Today, November 26th, 2024, is the last day of trading with the…